Bipolar Disorder
Understanding Bipolar Disorder (Manic-Depressive Illness, Bipolar Affective Disorder) diagnosis, clinical documentation, and medical coding is crucial for healthcare professionals. Find information on Bipolar Disorder ICD codes, diagnostic criteria, differential diagnosis, and treatment best practices for accurate medical records and effective patient care. This resource covers Bipolar I, Bipolar II, cyclothymic disorder, and related specified and unspecified bipolar and related disorders. Learn about proper medical coding for billing and insurance purposes.
Brain disorder causing unusual shifts in mood, energy, activity levels, and concentration.
Mania (highs), depression (lows), rapid cycling, psychosis, changes in sleep and appetite.
Outpatient psychiatry, inpatient hospitalization, community mental health centers.
ICD-10 Code Families
Complete code families applicable to F31.9
When to use each related code
| Description | When to use |
|---|---|
| Mood swings between mania and depression. | Use Bipolar Disorder for cyclical mood episodes including mania. Consider subtypes for specifying episode polarities. |
| Persistent low mood and loss of interest. | Use Major Depressive Disorder for sustained depressed mood, anhedonia, and other depressive symptoms lasting at least two weeks. Exclude bipolar if manic episodes present. |
| Chronic, fluctuating mood disturbance. | Use Cyclothymic Disorder for chronic mood instability with hypomanic and depressive symptoms not meeting criteria for full episodes. |
Best-practice checklist
- ✓Document manic/hypomanic episode symptoms (DSM-5 criteria)
- ✓Document depressive episode symptoms (DSM-5 criteria)
- ✓Specify bipolar type (I, II, or unspecified)
- ✓Document episode frequency, severity, and duration
- ✓Rule out medical/substance-induced causes
Common pitfalls to avoid
Coding Bipolar Disorder NOS (Not Otherwise Specified) when a more specific type (I, II, etc.) is documented leads to lower reimbursement and data inaccuracy.
Failing to code coexisting conditions like anxiety or substance use disorder with Bipolar impacts risk adjustment and quality metrics.
Incorrectly coding a manic/depressive episode as Bipolar Disorder without supporting documentation of a full disorder leads to coding errors.
Best-practice tips
- 01Document manic/depressive episodes with ICD-10 codes (F31.x).
- 02Use standardized terminology for mood episodes in CDI for Bipolar Disorder.
- 03Track medication adherence for Bipolar Disorder compliance.
- 04Screen for comorbidities like anxiety and substance use disorders (SUD).
- 05Ensure accurate family history for genetic predisposition to Bipolar.
Step-by-step checklist
- 1
Verify manic/hypomanic episode criteria (ICD-10 F31, DSM-5)
- 2
Assess depressive episode symptoms (ICD-10 F32, DSM-5)
- 3
Rule out medical/substance-induced causes (differential diagnosis)
- 4
Document episode frequency, severity, and duration for accurate coding
- 5
Screen for suicidality and safety plan (patient safety)
Ready-to-paste narrative
Patient presents with symptoms consistent with Bipolar Disorder (also known as Manic-Depressive Illness or Bipolar Affective Disorder). The patient's chief complaint includes episodic mood swings characterized by alternating periods of elevated mood (mania or hypomania) and depressed mood. These mood episodes meet the DSM-5 diagnostic criteria for Bipolar Disorder, including distinct periods of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased goal-directed activity or energy. The patient reports experiencing symptoms such as racing thoughts, decreased need for sleep, pressured speech, increased impulsivity, and inflated self-esteem during manic episodes. Depressive episodes are characterized by persistent sadness, loss of interest or pleasure, fatigue, feelings of worthlessness or guilt, difficulty concentrating, and recurrent thoughts of death or suicide. The patient's family history is positive for mood disorders, further supporting the diagnosis. Current differential diagnoses include Major Depressive Disorder, cyclothymia, and substance-induced mood disorder. A mental status examination reveals [insert specific findings, e.g., labile affect, pressured speech, flight of ideas]. The patient's current medication list includes [list medications]. Treatment plan includes initiation of mood stabilizer therapy with [medication name and dosage], along with psychotherapy focused on cognitive behavioral therapy (CBT) and psychoeducation regarding Bipolar Disorder management. Patient education regarding medication adherence, early warning signs of mood episodes, and lifestyle modifications was provided. Prognosis is guarded, with ongoing monitoring and medication management recommended. Follow-up appointment scheduled in two weeks to assess treatment response and adjust medication as needed. ICD-10 code F31 will be used for billing purposes. This documentation supports medical necessity for continued treatment and management of Bipolar Disorder.
Common questions and answers
What are the most effective differential diagnostic strategies for Bipolar Disorder vs. Borderline Personality Disorder in clinical practice?+
Differentiating Bipolar Disorder and Borderline Personality Disorder (BPD) can be challenging due to overlapping symptoms like mood lability and impulsivity. However, key distinctions exist. In Bipolar Disorder, mood episodes tend to be more sustained (lasting days to weeks), while in BPD, mood shifts are often rapid and reactive to interpersonal triggers. Furthermore, Bipolar Disorder's mood episodes are typically characterized by distinct periods of euthymia, whereas BPD presents with a more persistent pattern of emotional dysregulation. Consider implementing structured diagnostic interviews, such as the Structured Clinical Interview for DSM-5 (SCID-5), and obtaining a thorough history, including family history of mood disorders, to aid in accurate diagnosis. Explore how collateral information from family members or close friends can further clarify the clinical picture and differentiate between these complex presentations. Learn more about the nuances of mood episode characteristics and duration in distinguishing these disorders.
How can clinicians effectively manage rapid cycling Bipolar Disorder and minimize treatment-resistant symptoms?+
Rapid cycling Bipolar Disorder, characterized by four or more mood episodes within a 12-month period, presents unique management challenges. Treatment resistance is common, often requiring a combination of pharmacotherapy and psychosocial interventions. Consider implementing mood stabilizers, such as lithium or valproate, as first-line treatment options, along with atypical antipsychotics like quetiapine or olanzapine. Close monitoring of medication adherence and serum levels is crucial. Furthermore, explore how incorporating psychotherapy, specifically Cognitive Behavioral Therapy (CBT) or Interpersonal and Social Rhythm Therapy (IPSRT), can enhance medication efficacy and address comorbid conditions. Learn more about emerging treatment modalities, such as electroconvulsive therapy (ECT) or repetitive transcranial magnetic stimulation (rTMS), for treatment-resistant cases. Consider implementing strategies to identify and address potential contributing factors, such as substance use or sleep disturbances.
What are the evidence-based best practices for integrating pharmacotherapy and psychotherapy in treating Bipolar II Disorder in adults?+
Integrating pharmacotherapy and psychotherapy is crucial for optimal management of Bipolar II Disorder in adults. Mood stabilizers, such as lamotrigine or lithium, are often considered first-line pharmacotherapeutic agents for managing both depressive and hypomanic episodes. Explore how adding antidepressants, under careful monitoring for mood switching, can be beneficial for some individuals experiencing significant depressive symptoms. Furthermore, consider implementing evidence-based psychotherapeutic approaches, such as CBT and Interpersonal and Social Rhythm Therapy (IPSRT), to address cognitive distortions, improve coping skills, and stabilize daily routines. Learn more about how combining pharmacotherapy and psychotherapy synergistically enhances treatment outcomes and reduces relapse rates. Consider implementing collaborative care models, involving psychiatrists, therapists, and primary care physicians, to ensure comprehensive and coordinated care for individuals with Bipolar II Disorder.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.